Skip to content

Clinical trials

Phase 1/2 Dyslipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 1/2 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20091
20121
20141
20212
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Enrolling by invitation1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aga Khan University1
AstraZeneca1
Chang Gung Memorial Hospital1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Federico II University1
Guang'anmen Hospital of China Academy of Chinese Medical Sciences1
Johns Hopkins University1
Radiant Research1
Resverlogix Corp1
University of Cincinnati1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias10
Metabolic Syndrome3
Diabetes Mellitus2
Obesity2
Acute Coronary Syndrome1
Atherosclerosis1
Cardiovascular Diseases1
Diabetes Mellitus, Type 21
Epilepsy1
HIV Infections1

Trials

Showing 76 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.